xeloda 500 mg Capecitabine Tablet

Trade Name: Xeloda

Manufacturer: Roche Products India Pvt Ltd

Presentation: Tablet

Strength: 500mg

What are the uses of Xeloda 500 mg tablets?

Xeloda 500 mg Tablet 10 has a place with a gathering of medications known as’ against disease ‘, used to treat breast, colon, and stomach malignant growth. Disease is a condition where cells in a particular piece of the body develop and recreate wildly.

what are the benefits of xeloda 500 mg tablets?

XELODA 500MG contains capecitabine, which has a place in a group of medications called cytostatic drugs, which stop the development of malignant growth cells. It is utilised to treat colon, rectal, gastric, or bosom diseases and assists in forestalling new events of colon malignant growth after complete expulsion of the cancer by medical procedure.

How do Xeloda tablets 500 mg work?

Xeloda 500 mg Tablet is an anticancer medicine. Inside the body, this medication gets changed into 5-fluorouracil (a substance). This substance hampers the amalgamation of hereditary materials (RNA and DNA) in the disease cells, consequently meddling with their growth. 25-Jan-2021

Can Xeloda 500mg cure cancer?

The medication was first endorsed in the US and EU in 2001 as monotherapy for treating colorectal malignant growth. From that point forward, Xeloda has been endorsed for treating different types of malignant growth, like gastric disease and metastatic bosom malignant growth. Xeloda was encouraged to treat these diseases as monotherapy as well as in combination with other medications.

What should I eat when taking Xeloda 500mg?

  • Food sources high in dissolvable fibre include:
  • fruit puree.
  • bananas.
  • canned organic products.
  • orange segments.
  • boiled potatoes.
  • white rice.
  • items made with white flour.
  • cereal.
  • cream of rice.
  • cream of wheat.
  • farina.

How long is Xeloda effective?

In a stage II preliminary of 163 paclitaxel-unmanageable patients with metastatic bosom malignant growth, the general reaction rate with Xeloda was 20%, with three complete reactions, and the median endurance was 12.8 months. A total of 20% of patients encountered a clinical benefit response (a composite evaluation of clinical advantage).

If you are looking for another product or brand click on clokeran.